United Therapeutics UTHR Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from United Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's quick ratio?
- United Therapeutics (UTHR) reported quick ratio of 4.5× in Q1 2026.
- How has United Therapeutics's quick ratio changed year-over-year?
- United Therapeutics's quick ratio decreased by 14.1% year-over-year, from 5.2× to 4.5×.
- What is the long-term trend for United Therapeutics's quick ratio?
- Over 4 years (2021 to 2025), United Therapeutics's quick ratio has grown at a -3.2% compound annual growth rate (CAGR), from 28× to 24.5×.
- What does quick ratio mean?
- Can the company cover short-term bills without having to sell inventory first?
- How do you interpret quick ratio?
- More conservative than the current ratio. A wide gap between the two flags heavy reliance on inventory to meet near-term obligations.
- How does quick ratio compare across companies?
- Most informative for inventory-heavy businesses; converges with the current ratio for firms that carry little inventory.